[PERSON]
Mounjaro
Featured in 8 tracked stories · first seen
Situations
South Korea obesity and diabetes medication regulation
4 clusters · 19 sources · last updated
Latest: South Korea launches crackdown on illegal obesity drug sales
In late October 2026, the South Korean Ministry of Food and Drug Safety expanded the approved indications for Mounjaro (tirzepatide). The medication is now approved for adult type 2 diabetes patients with established car
GLP-1 drugs: clinical trends, safety, and market shifts
343 clusters · 1318 sources · last updated
Latest: FDA issues warning for GLP-1 drugs over vision loss risks
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, neurodegenerative, heart, sleep apnea, and addiction healt
Also covered in
-
Tirzepatide discontinuation linked to psychiatric symptoms in clinical report
[HEALTH] · 6 sources ·
-
Weight loss medications and habit formation for fat reduction
[HEALTH] · 2 sources ·
-
Brazil sees 138.5% surge in GLP-1 medication searches
[HEALTH] · 2 sources ·